Yes and many more throughout the world as it is a huge market I agree. I just get the impression that you feel that CYP has jumped through hoops that haven't even began to be presented yet. I would like to be wrong as I have bad knees, but I think the whole concept of safely duplicating and manufacturing stem cells is years away. The FDA can't understand or refuses to appreciate or accept naturally derived stem cell therapy up until now. That might change with the new resubmission by MSB but who knows, it could be another block for this science. The product that CYP offers is in no way similar to the one that MSB offers, and only a fool would claim that.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)